Dermatology Medical News about mycosis fungoides

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Doctors and the DEA Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Clinical characteristics and course of CD8+ cytotoxic variant of mycosis fungoides: a case series of seven patients
British Journal of Dermatology, 06/25/09

Nikolaou V et al. - Special clinical characteristics, such as hyperpigmentation and poikiloderma, are often noted in CD8+ MF cases. In series CD8+ MF presented with a long-standing disease and indolent course suggesting that CD8+ cytotoxic immunophenotype may represent a marker of mild biological behaviour.

<< Previous
Adherence to topical dermatological therapy: lessons from oral...

Next >>
Significant upregulation of antimicrobial peptides and proteins...

Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sezary syndrome
Journal of Cutaneous Pathology, 11/06/09 Relevance Score: 66%

Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome
Annals of Oncology, 11/16/09 Relevance Score: 64%

Cerebral mycosis: 7-year retrospective series in a tertiary center
Neuropathology, 11/03/09 Relevance Score: 64%

Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma
Journal of Clinical Oncology, 10/20/09 Relevance Score: 64%

A practical approach to using methotrexate
Dermatology in Practice, 10/14/09 Relevance Score: 62%